Shanghai Bao Pharma files HKEX next-day disclosure return on share repurchase

PUBT · 2d ago
Shanghai Bao Pharma files HKEX next-day disclosure return on share repurchase
  • Shanghai Bao Pharmaceuticals repurchased 119,500 H shares on Sept. 2, 2026 for treasury.
  • Buyback price range HKD 16.46 to HKD 16.96; aggregate cost HKD 1.99 million.
  • Cancelled shares: 0; total repurchased shares: 119,500.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Bao Pharmaceuticals Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260902-12316324), on September 02, 2026, and is solely responsible for the information contained therein.